Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+T cells

Epstein-Barr viral miRNAs inhibit antiviral CD4 + T cell responses targeting IL-12 and peptide processing

(2016) Takanobu Tagawa et al.   JOURNAL OF EXPERIMENTAL MEDICINE

K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus

(2015) Lisa Steinbrück et al.   JOURNAL OF VIROLOGY

The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II

(2015) Laura L. Quinn et al.   JOURNAL OF VIROLOGY

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells

(2015) Chiara Rancan et al.   PLoS Pathogens

Viral Inhibition of the Transporter Associated with Antigen Processing (TAP): A Striking Example of Functional Convergent Evolution

(2015) Marieke C. Verweij et al.   PLoS Pathogens

IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo

(2013) Gabriel R. Starbeck-Miller et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Virus-Encoded microRNAs: An Overview and a Look to the Future

(2013) Rodney P. Kincaid et al.   PLoS Pathogens

EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency

(2012) Kasandra J Riley et al.   EMBO JOURNAL

Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1  Production

(2012) M. Haneklaus et al.   JOURNAL OF IMMUNOLOGY

Are membrane proteins favored over cytosolic proteins in TAP-independent processing pathways?

(2012) Margarita Del Val et al.   MOLECULAR IMMUNOLOGY

Viral interference with antigen presentation: Trapping TAP

(2012) Maaike E. Ressing et al.   MOLECULAR IMMUNOLOGY

RNAs in Epstein-Barr virions control early steps of infection

(2012) S. Jochum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination

(2012) Simon Jochum et al.   PLoS Pathogens

The Members of an Epstein-Barr Virus MicroRNA Cluster Cooperate To Transform B Lymphocytes

(2011) R. Feederle et al.   JOURNAL OF VIROLOGY

The Lytic Phase of Epstein-Barr Virus Requires a Viral Genome with 5-Methylcytosine Residues in CpG Sites

(2011) M. Kalla et al.   JOURNAL OF VIROLOGY

Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs

(2011) David M Garcia et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus

(2011) Regina Feederle et al.   PLoS Pathogens

A Novel Persistence Associated EBV miRNA Expression Profile Is Disrupted in Neoplasia

(2011) Jin Qiu et al.   PLoS Pathogens

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

(2010) A. Moosmann et al.   BLOOD

Systematic Analysis of Viral and Cellular MicroRNA Targets in Cells Latently Infected with Human γ-Herpesviruses by RISC Immunoprecipitation Assay

(2010) Lars Dölken et al.   Cell Host & Microbe

Toll-Like Receptor Agonists Synergistically Increase Proliferation and Activation of B Cells by Epstein-Barr Virus

(2010) S. Iskra et al.   JOURNAL OF VIROLOGY

The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways

(2010) J. Zuo et al.   JOURNAL OF VIROLOGY

Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells

(2010) Eri Seto et al.   PLoS Pathogens

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells

(2009) Daphna Nachmani et al.   Cell Host & Microbe

Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation

(2009) D. Horst et al.   JOURNAL OF IMMUNOLOGY

Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells

(2009) Takeshi Haraguchi et al.   NUCLEIC ACIDS RESEARCH

The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation

(2009) Jianmin Zuo et al.   PLoS Pathogens

Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle

(2009) Nathan P. Croft et al.   PLoS Pathogens

EBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3

(2008) T. Xia et al.   CANCER RESEARCH

Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry

(2008) Andreas O. Weinzierl et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Conditional Immortalization of Human B Cells by CD40 Ligation

(2008) Martina Wiesner et al.   PLoS One